Isradipine (Actavis Pharma, Inc.)
Welcome to the PulseAid listing for the Isradipine drug offered from Actavis Pharma, Inc.. This Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Actavis Pharma, Inc. |
NON-PROPRIETARY NAME: | Isradipine |
SUBSTANCE NAME: | ISRADIPINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2004-01-05 |
END MARKETING DATE: | 0000-00-00 |
Isradipine HUMAN PRESCRIPTION DRUG Details:
Item Description | Isradipine from Actavis Pharma, Inc. |
LABELER NAME: | Actavis Pharma, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 2.5(mg/1) |
START MARKETING DATE: | 2004-01-05 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 16252-539_112d44ff-a0cd-421f-aebd-d46f17f37825 |
PRODUCT NDC: | 16252-539 |
APPLICATION NUMBER: | ANDA077317 |
Other ISRADIPINE Pharmaceutical Manufacturers / Labelers: